Sharon Bio-Medicine Ltd.
NSE: SHARONBIO | BSE: 532908
₹3.30
₹-0.15
(-4.35%)
As on 28-Mar-2019IST
Market cap
₹2 Cr
Revenue (TTM)
₹197 Cr
P/E Ratio
0.1
P/B Ratio
-0.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹23 Cr
-
ROE
62.7 %
-
ROCE
25.2 %
-
Industry P/E
--
-
EV/EBITDA
27
-
Debt to Equity
2.5
-
Book Value
₹19532.4
-
EPS
₹9271.6
-
Face value
2
-
Shares outstanding
5,755,625
10 Years Aggregate
CFO
₹88.10 Cr
EBITDA
₹-352.70 Cr
Net Profit
₹-731.77 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sharon Bio-Medicine
| -34.7 | -4.3 | -34.7 | -42.1 | -34.4 | -39.9 | -- |
|
BSE Sensex*
| -11.1 | -4.0 | -9.7 | -8.5 | 7.0 | 8.7 | 11.3 |
|
BSE Healthcare#
| 8.9 | 8.8 | 9.5 | 11.4 | 27.0 | 14.4 | 11.8 |
|
Company
|
2018
|
2017
|
2016
|
2015
|
2014
|
|---|---|---|---|---|---|
|
Sharon Bio-Medicine
| -29.4 | -21.0 | -66.8 | -25.2 | -14.2 |
|
BSE Sensex
| 5.9 | 27.9 | 1.9 | -5.0 | 29.9 |
|
BSE Healthcare
| -5.9 | 0.5 | -12.9 | 15.1 | 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sharon Bio-Medicine
|
3.3 | 1.9 | 197.5 | 23.2 | 7.5 | 62.7 | 0.1 | -0.1 |
| 2,799.1 | 22,902.2 | 1,339.4 | 356.4 | 33.2 | 23.2 | 64.3 | 13.9 | |
| 428.1 | 16,431.3 | 2,268.6 | 150.1 | 10.6 | 5.4 | 91.7 | 4.2 | |
| 731.5 | 18,126.3 | 5,365.6 | 595.0 | 16.6 | 13.3 | 30.5 | 3.6 | |
| 1,165.6 | 20,913.8 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 13.4 | 2.4 | |
| 1,811.3 | 20,737.1 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.6 | |
| 175.1 | 23,261.8 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 997.4 | 16,475.4 | 1,284.3 | 134.4 | -- | 30.7 | 122.6 | 13.5 | |
| 466.3 | 18,819.1 | 3,738.7 | 316.7 | 12.5 | 7.5 | 59.4 | 3.9 | |
| 1,571.5 | 25,547.8 | 3,373.0 | 199.0 | 12.6 | 5.9 | 119.9 | 5.2 |
Shareholding Pattern
View DetailsNews & Analysis
All News
2 min read•By Vikas Vardhan
About Sharon Bio-Medicine
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1989
-
Chairman
--
-
Managing Director
--
-
Headquarters
Raigad, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Sharon Bio-Medicine
What is the current share price of Sharon Bio-Medicine Ltd Today?
The share price of Sharon Bio-Medicine Ltd is ₹3.30 (NSE) and ₹3.21 (BSE) as of 28-Mar-2019 IST. Sharon Bio-Medicine Ltd has given a return of -34.42% in the last 3 years.
What is the current PB & PE ratio of Sharon Bio-Medicine Ltd?
The P/E ratio of Sharon Bio-Medicine Ltd is 0.10 times as on 28-Mar-2019.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2017
|
0.00
|
-0.17
|
What is the 52 Week High and Low of Sharon Bio-Medicine Ltd?
The 52-week high and low of Sharon Bio-Medicine Ltd are Rs -- and Rs -- as of 19-May-2026.
What is the market cap of Sharon Bio-Medicine Ltd?
Sharon Bio-Medicine Ltd has a market capitalisation of ₹ 2 Cr as on 28-Mar-2019. As per SEBI classification, it is a company.
Should I invest in Sharon Bio-Medicine Ltd?
Before investing in Sharon Bio-Medicine Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.